- Home
- DYAI vs MBOT Comparison
DYAI vs MBOT Comparison
Compare DYAI & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- MBOT
- Stock Information
- Founded
- DYAI 1979
- MBOT 2010
- Country
- DYAI United States
- MBOT United States
- Employees
- DYAI N/A
- MBOT N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- MBOT Medical/Dental Instruments
- Sector
- DYAI Health Care
- MBOT Health Care
- Exchange
- DYAI Nasdaq
- MBOT Nasdaq
- Market Cap
- DYAI 54.4M
- MBOT 50.4M
- IPO Year
- DYAI 2004
- MBOT N/A
- Fundamental
- Price
- DYAI $1.38
- MBOT $1.49
- Analyst Decision
- DYAI Strong Buy
- MBOT Strong Buy
- Analyst Count
- DYAI 1
- MBOT 1
- Target Price
- DYAI $6.00
- MBOT $9.00
- AVG Volume (30 Days)
- DYAI 59.9K
- MBOT 810.9K
- Earning Date
- DYAI 03-26-2025
- MBOT 03-25-2025
- Dividend Yield
- DYAI N/A
- MBOT N/A
- EPS Growth
- DYAI N/A
- MBOT N/A
- EPS
- DYAI N/A
- MBOT N/A
- Revenue
- DYAI $3,495,389.00
- MBOT N/A
- Revenue This Year
- DYAI $51.30
- MBOT N/A
- Revenue Next Year
- DYAI $73.26
- MBOT N/A
- P/E Ratio
- DYAI N/A
- MBOT N/A
- Revenue Growth
- DYAI 20.58
- MBOT N/A
- 52 Week Low
- DYAI $0.93
- MBOT $0.82
- 52 Week High
- DYAI $2.67
- MBOT $3.38
- Technical
- Relative Strength Index (RSI)
- DYAI 46.47
- MBOT 44.53
- Support Level
- DYAI $1.29
- MBOT $1.41
- Resistance Level
- DYAI $1.45
- MBOT $1.53
- Average True Range (ATR)
- DYAI 0.10
- MBOT 0.12
- MACD
- DYAI 0.00
- MBOT -0.00
- Stochastic Oscillator
- DYAI 41.38
- MBOT 20.00
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.